In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infections

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1506-1511

  Rybak, Rachel J ^a   Hartline, Caroll B ^a   Qiu, Yao Ling ^b   Zemlicka, Jiri ^b   Harden, Emma ^a   Marshall, Gwen ^a   Sommadossi, Jean Pierre ^a   Kern, Earl R ^a,c  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 6 CHLOROPURINE DERIVATIVE; 2 AMINO 6 CYCLOPROPYLAMINO 9 [2 (HYDROXYMETHYL)CYCLOPROPYLIDENEMETHYL]PURINE; 2 AMINO 6 CYCLOPROPYLAMINO DERIVATIVE; 2 AMINO 6 CYCLOPROPYLAMINO DERIVATIVE PRODRUG; 2 AMINO 6 METHOXYPURINE DERIVATIVE; 2 AMINO 6 METHOXYPURINE DERIVATIVE PRODRUG; 2,6 DIAMINOPURINE DERIVATIVE; 2,6 DIAMINOPURINE DERIVATIVE PRODRUG; CYCLOPROPANE DERIVATIVE; QYL 284A; QYL 418; QYL 468; QYL 546; QYL 587A; QYL 678; QYL 685; QYL 788; QYL 941; QYL 972; QYL 975; SYNCYTOL; SYNGUANOL; SYNGUANOL PRODRUG; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BURST FORMING UNIT E; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG ACTIVITY; DRUG EFFICACY; EMBRYO; EPSTEIN BARR VIRUS; HERPES; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS;

ADULT; ANIMALS; CYCLOPROPANES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HERPESVIRIDAE INFECTIONS; HUMANS; MICE; NUCLEOSIDES; PRODRUGS;

EID: 0034037288     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1506-1511.2000     Document Type: Article

References (29)

1. Alford, C. A., and W. J. Britt. 1993. Cytomegalovirus, p. 227-255. In B. Roizman, R. J. Whitley, and C. Lopez (ed.), The human herpesviruses. Raven Press, New York, N.Y.
2. De Castro, L. M., E. R. Kern, E. DeClercq, A. Ghaffar, E. P. Mayer, P. E. Vogt, and J. D. Gangemi. 1991. Phosphonylmethoxyalkylpurine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS. Antivir. Res. 16:101-114.
3. Drew, W. L., R. C. Miner, D. F. Busch, S. E. Follansbee, J. Gullett, S. G. Mehalko, S. M. Gordon, W. F. Owen, Jr., T. R. Matthews, W. C. Buhles, and B. DeArmond. 1991. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J. Infect. Dis. 163:716-719.
4. Freitas, V. R., D. F. Smee, M. Chernow, R. Bothme, and T. R. Matthews. 1985. Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses. Antimicrob. Agents Chemother. 28:240-245.
5. Gershon, A. A., E. Gold, and G. A. Nankervis. 1997. Cytomegalovirus, p. 229-251. In A. S. Evans and R. A. Kaslow (ed.), Viral infections of humans: epidemiology and control. Plenum Publishing Co., New York, N.Y.
6. Hayashi, S., S. Phadtare, J. Zemlicka, M. Matsukura, H. Mitsuya, and S. Broder. 1988. Adenallene and cytallene: acyclic nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 85:6127-6131.
7. Kern, E. R., J. C. Overall, Jr., and L. A. Glasgow. 1973. Herpesvirus hominis infection in newborn mice. 1. An experimental model and therapy with iododeoxyuridine. J. Infect. Dis. 128:290-299.
8. Kern, E. R. 1988. Animals models as assay systems for the development of antivirals, p. 149-172. In E. De Clercq and R. T. Walker (ed.), Antiviral drug development. Plenum Publishing Co., New York, N.Y.
9. Kern, E. R. 1990. Preclinical evaluation of antiviral agents: in vitro and animal model testing, p. 87-123. In G. J. Galasso, R. J. Whitley, and T. C. Merigan (ed.), Antiviral agents and viral diseases of man, 3rd ed. Raven Press, New York, N.Y.
10. Kern, E. R. 1991. Value of animal models to evaluate agents with potential activity against human cytomegalovirus. Transplant. Proc. 23:152-155.
11. Kern, E. R. 1997. Preclinical evaluation of antiviral agents, p. 79-111. In G. J. Galasso, R. J. Whitley, and T. C. Merigan (ed.), Antiviral agents and human viral diseases, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
12. Kern, E. R. 1999. Animal models for cytomegalovirus infections: murine CMV, p. 927-934. In O. Zak, M. Sande, C. Carbon, R. Kanisky, T. O'Reilly, and E. R. Kern (ed.), Handbook of animal models of infection. Academic Press, New York, N.Y.
13. Mocarski, E. D., Jr. 1993. Cytomegalovirus biology and replication, p. 173-226. In B. Roizman, R. J. Whitley, and C. Lopez (ed.), The human herpesviruses. Raven Press, New York, N.Y.
14. Neyts, J., J. Balzarini, L. Naesens, and E. De Clercq. 1992. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. J. Med. Virol. 37:67-71.
15. Neyts, J., H. Sobis, R. Snoeck, E. Vandeputte, and E. De Clercq. 1993. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immuno-competent and immunodeficient mice. Eur. J. Clin. Microbiol. Infect. Dis. 12:269-279.
16. Overall, J. C., Jr., E. R. Kern, and L. A. Glasgow. 1976. Effective antiviral chemotherapy in cytomegalovirus infection of mice. J. Infect. Dis. 133(Suppl.):A237-A244.
17. Perigaud, C., J.-L. Girardet, L. Lefebvre, M.-Y. Xie, A.-M. Aubertin, A. Kirn, G. Gosselin, J.-L. Imbach, and J.-P. Sommadossi. 1996. Comparison of cytotoxicity of mononucleoside phosphotriester derivatives bearing biolabile phosphate protecting groups in normal human bone marrow progenitor cells. Antivir. Chem. Chemother. 7:338-345.
18. Qiu, Y.-L., M. B. Ksebati, R. G. Ptak, B. Y. Fan, J. M. Breitenbach, J.-S. Lin, Y.-C. Cheng, E. R. Kern, J. C. Drach, and J. Zemlicka. 1998. (Z)- and (E)-2-((hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity. J. Med. Chem. 41:10-23.
19. Qiu, Y.-L., A. Hempel, N. Camerman, A. Camerman, F. Geiser, R. G. Ptak, J. M. Breitenbach, T. Kira, L. Li, E. Gullen, Y.-C. Cheng, J. C. Drach, and J. Zemlicka. 1998. (R)-(-) and (S)-(+)-synadenol: synthesis, absolute configuration, and enantioseleclivity of antiviral effect. J. Med. Chem. 41:5257-5264.
20. Qiu, Y.-L., R. G. Ptak, J. M. Breitenbach, J.-S. Lin, Y.-C. Cheng, E. R. Kern, J. C. Drach, and J. Zemlicka. 1998. (Z)- and (E)-2-(hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents. Antivir. Chem. Chemother. 9:341-352.
21. Qiu, Y.-L., R. G. Ptak, J. M. Breitenbach, J.-S. Lin, Y.-C. Cheng, J. C. Drach, E. R. Kern, and J. Zemlicka. 1999. Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides. Antivir. Res. 43:37-53.
22. Reddehase, M. J., M. Balthesen, M. Rapp, S. Jonjic, I. Pavic, and U. H. Koszinowski. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185-193.
23. Rybak, R. J., J. Zemlicka, Y.-L. Qui, C. B. Hartline, and E. R. Kern. 1999. Effective treatment of murine cytomegalovirus infections with methylenecyclopropane analogues of nucleosides. Antivir. Res. 43:175-188.
24. Sinzger, C., and G. Jahn. 1996. Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39:302-319.
25. Smee, D. F., J. L. B. Morris, J. A. Leonhardt, J. R. Mead, A. Holy, and R. W. Sidwell. 1992. Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine. Antimicrob. Agents Chemother. 36:1837-1842.
26. Sommadossi, J.-P., and R. Carlisle. 1987. Toxicity of 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro. Antimicrob. Agents Chemother. 31:452-454.
27. Sommadossi, J.-P., R. F. Schinazi, C. K. Chu, and M.-Y. Xie. 1992. Comparison of cytotoxicity of the (-) and (+)-enantiomer of 2′,3′-dideoxy-3′-thiacytidine in normal human bone marrow progenitor cells. Biochem. Pharmacol. 44:1921-1925.
28. Tsutsui, Y., A. Kashiwai, N. Kawamura, S. Aiba-Masago, and I. Kosugi. 1995. Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch. Virol. 140:1725-1736.
29. Uchida, H., E. N. Kodoma, K. Yoshimura, Y. Maeda, P. Kosalaraksa, V. Maroun. Y.-L. Qiu, J. Zemlicka, and H. Mitsuya. 1999. In vitro anti-human immunodeficiency virus activities of Z- and E-methylenecyclopropane nucleoside analogues and their phosphoro-L-alaninate diesters. Antimicrob. Agents Chemother. 43:1487-1490.